Pluri Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PLUR, updated each market day.
PLUR AI Sentiment
AI sees no strong directional signal for Pluri Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Pluri Inc. Common Stock
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Sector
Exchange
Market Cap
$34,072,018
Cap Tier
Employees
142
Headquarters
HAIFA
Listed Since
Oct. 9, 1991
Website
PLUR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PLUR Volatility
Pluri Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
